Back to results
US 8,986,683 B2Granted
Combined use of ribonuclease and artemisinin
AssigneesShanghai Biomodel Organism Science & Technology Co., Ltd., Shanghai Research Center for Model Organisms
InventorsQingcheng Wang, Ruling Shen, Jun Li, Jian Fei, Zhugang Wang
Life of this patent
Estimating the term…
Abstract
The invention discloses a kit which comprises a formulation containing artemisinin or the derivatives thereof, a formulation containing ribonuclease, and a specification.
Claims8
A kit for treating tumors, consisting of:
- a formulation containing an artemisinin derivative;
- a formulation containing ribonuclease;
- and
- a specification,
- wherein the artemisinin derivative and the ribnuclease are the only active ingredients contained in the kit for treating the tumors, where (1) the artemisinin derivative and (2) the ribonuclease are present in amounts effective for treating a tumor in a subject in need thereof,
- wherein the artemisinin derivative is artemether, dihydroartemisinin, artesunate, arteether or dihydroartemether.
3 more elements
Dependencies are inferred from the claim text.